Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$2.72B |
| 2 |
Meta Platforms (Facebook)
META
|
+$660M |
| 3 |
Micron Technology
MU
|
+$605M |
| 4 |
Mastercard
MA
|
+$497M |
| 5 |
Tesla
TSLA
|
+$495M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.33B |
| 2 |
Visa
V
|
+$1.26B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.23B |
| 4 |
Lam Research
LRCX
|
+$699M |
| 5 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$681M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 79.37% |
| 2 | Technology | 4.49% |
| 3 | Healthcare | 2.99% |
| 4 | Financials | 2.85% |
| 5 | Industrials | 2.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
SNOY
12001
YieldMax SNOW Option Income Strategy ETF
SNOY
$68.6M
| $96.7K | ﹤0.01% |
12,403
-6,527
| -34% | -$64.2K |
2025 Q4
1 quarter
|
|
|
PPT
12002
Franklin Premier Income Trust
PPT
$313M
| $96.6K | ﹤0.01% |
27,218
+9,574
| +54% | +$34.3K |
2025 Q4
1 quarter
|
|
12003
PUT
Rezolute
RZLT
$388M
| $96.4K | ﹤0.01% |
31,600
-11,600
| -27% | -$34.8K |
2024 Q3
6 quarters
|
|
12004
Sono-Tek
SOTK
$97.4M
| $96.1K | ﹤0.01% |
23,663
+3,633
| +18% | +$15K |
2025 Q4
1 quarter
|
|
|
CNTB
12005
PUT
Connect Biopharma Holdings
CNTB
$58.4M
| $95.9K | ﹤0.01% |
+36,600
| New | +$95.4K |
2026 Q1
0 quarters
|
|
12006
CALL
Grove Collaborative
GROV
$44.4M
| $95.9K | ﹤0.01% |
+74,900
| New | +$102K |
2026 Q1
0 quarters
|
|
12007
Kiora Pharmaceuticals
KPRX
$11.3M
| $95.6K | ﹤0.01% |
49,533
+27,152
| +121% | +$57.3K |
2025 Q3
2 quarters
|
|
12008
CALL
Cerus
CERS
$459M
| $95.2K | ﹤0.01% |
52,300
-22,100
| -30% | -$48.2K |
2020 Q1
24 quarters
|
|
12009
CALL
Stagwell
STGW
$2.04B
| $95K | ﹤0.01% |
+15,100
| New | +$84.4K |
2026 Q1
0 quarters
|
|
12010
CALL
Voyager Therapeutics
VYGR
$151M
| $95K | ﹤0.01% |
24,600
-1,600
| -6% | -$6.3K |
2019 Q1
28 quarters
|
|
12011
PUT
Protalix BioTherapeutics
PLX
$218M
| $94.8K | ﹤0.01% |
43,700
+16,100
| +58% | +$40K |
2022 Q4
13 quarters
|
|
12012
Avita Medical
RCEL
$393M
| $94.8K | ﹤0.01% |
25,624
+5,434
| +27% | +$22.8K |
2025 Q4
1 quarter
|
|
|
QUBX
12013
CALL
Tradr 2X Long QUBT Daily ETF
QUBX
$88.1M
| $94.7K | ﹤0.01% |
3,155
-3,735
| -54% | -$244K |
2025 Q3
2 quarters
|
|
|
GRFS
12014
CALL
Grifois
GRFS
$4.98B
| $94.6K | ﹤0.01% |
+11,800
| New | +$104K |
2026 Q1
0 quarters
|
|
|
FLNT
12015
Fluent
FLNT
$94.2M
| $94.6K | ﹤0.01% |
+29,929
| New | +$100K |
2026 Q1
0 quarters
|
|
12016
Aware
AWRE
$24M
| $94.5K | ﹤0.01% |
75,560
+34,640
| +85% | +$57.7K |
2025 Q4
1 quarter
|
|
12017
PUT
Direxion Daily S&P Oil & Gas Exp. & Prod. Bear 2X ETF
DRIP
$126M
| $94.4K | ﹤0.01% |
2,280
-4,690
| -67% | -$305K |
2019 Q3
26 quarters
|
|
|
COYY
12018
CALL
GraniteShares YieldBOOST COIN ETF
COYY
$16.2M
| $94.2K | ﹤0.01% |
3,667
+1,734
| +90% | +$57.9K |
2025 Q4
1 quarter
|
|
12019
CALL
Cosmos Holdings
COSM
$38.2M
| $94K | ﹤0.01% |
296,300
+280,700
| +1,799% | +$118K |
2025 Q4
1 quarter
|
|
12020
CALL
KORU Medical Systems
KRMD
$137M
| $93.7K | ﹤0.01% |
21,700
+10,000
| +85% | +$49.6K |
2025 Q4
1 quarter
|
|
12021
PUT
Santander
BSBR
$40.4B
| $93.7K | ﹤0.01% |
+15,800
| New | +$101K |
2026 Q1
0 quarters
|
|
12022
CALL
Quanterix
QTRX
$172M
| $93.6K | ﹤0.01% |
+26,600
| New | +$155K |
2026 Q1
0 quarters
|
|
|
POM
12023
Pomdoctor Ltd
POM
$7.97M
| $93.6K | ﹤0.01% |
+20,256
| New | +$104K |
2026 Q1
0 quarters
|
|
12024
PUT
Oportun Financial
OPRT
$384M
| $93.6K | ﹤0.01% |
+20,300
| New | +$103K |
2026 Q1
0 quarters
|
|
|
AIFC
12025
PUT
AI Financial Corp
AIFC
$70.4M
| $93.4K | ﹤0.01% |
84,100
-56,500
| -40% | -$92K |
2025 Q2
3 quarters
|
|
Similar funds
Citadel Advisors's Q1 2026 Portfolio in Review
As of Q1 2026, Citadel Advisors held 14,860 positions worth $618B, down 7.1% from $666B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Citadel Advisors's Q1 2026 filing shows 2,347 new, 5,138 increased, 5,286 reduced and 2,003 closed positions. Its largest new stake was iShares 7-10 Year Treasury Bond ETF: 3,431,225 shares worth $327M. The largest sale was Amazon, an estimated $1.33B.
By sector, the portfolio is most concentrated in Miscellaneous at 79% of assets, down from 80% a quarter earlier, followed by Technology and Healthcare.
- Citadel Advisors's largest Q1 2026 buy was iShares 7-10 Year Treasury Bond ETF: 3,431,225 shares worth $327M.
- Citadel Advisors added most to iShares Core S&P 500 ETF in Q1 2026, an estimated $2.72B increase.
- Citadel Advisors's biggest Q1 2026 reduction was Amazon, cutting an estimated $1.33B.
- Citadel Advisors fully exited CyberArk in Q1 2026, selling an estimated $305M.
- Citadel Advisors's ten largest holdings make up 22% of its $618B portfolio in Q1 2026.
- Citadel Advisors opened 2,347 new positions and closed 2,003 in Q1 2026.
- Citadel Advisors's portfolio value fell 7.1% quarter-over-quarter to $618B.
Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.